Clinical Trials Contact Us Careers Search Press Releases Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Keywords Go Nov 30, 2021 BioMarin to Hold Virtual R&D Day at 11:00am ET Today Nov 29, 2021 BioMarin to Participate in Two Upcoming Virtual Investor Conferences Nov 19, 2021 BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates Oct 27, 2021 BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates Oct 25, 2021 BioMarin to Participate in Four Upcoming Virtual Investor Conferences Show 5 per page «123456789…142» Navigate Our Motivation Our Treatments Our Company Investors & Media About Our History Our Products Our Pipeline Leadership Team Board of Directors Diversity, Equity & Inclusion Contact Global Contact Information Our Locations Report a Product Complaint Report Adverse Event Publication Data Request Funding & Support Connect Careers LinkedIn Facebook Instagram YouTube Privacy Policy Terms of Use Site Map Supplier Information Slavery Act Statement Glossary Contact Us © 2021 BioMarin. All rights reserved.